New biomarker to identify gluten-free celiac disease

Researchers Nora Fernández-Jiménez and José Ramón Bilbao Catala. Ed. UPV/EHU

Researchers at UPV-EHU and BioCruces have discovered a new biomarker to diagnose celiac disease that would allow use with people who follow a gluten-free diet. One of the difficulties in diagnosing celiac disease is that patients need to take gluten to properly diagnose the disease through endoscopy. However, with this biomarker I do not need to take gluten. In addition, more and more people resort to eliminating gluten from their diet before consulting with a specialist, making it difficult to diagnose the disease reliably. Also in these cases it will facilitate the diagnosis.

With the new method, analyzing the expression of the UBE2L3 gene in blood, a person can know if he has celiac disease or not. According to the authors in their press release, “the phenomenon of self-diagnosed sensitivity to gluten grows more and more, reaching 12-13% of the general population in Italy and the United Kingdom.” The research has been published in the journal Human Molecular Genetics and has patented its discovery.

Gehitu iruzkin bat

Saioa hasi iruzkinak uzteko.

Eusko Jaurlaritzako Industria, Merkataritza eta Turismo Saila
MAIER Koop. Elk.
KIDE Koop. Elk.
ULMA Koop. Elk.
EIKA Koop. Elk.
LAGUN ARO Koop. Elk.